BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Diabetes. Sep 15, 2026; 17(9): 120935
Published online Sep 15, 2026. doi: 10.4239/wjd.120935
Figure 1
Figure 1 Streptozotocin-high-fat diet-induced rats exhibit significant characteristics of type 2 diabetic peripheral neuropathy. A and B: Blood glucose (A) and body weight (B) of rats in the control and type 2 diabetic peripheral neuropathy (T2DPN) groups after streptozotocin (STZ) injection; C and D: Glucose tolerance test (C) and the related area under the curve (D) in the control and T2DPN groups; E-I: Serum levels of insulin (E), triglyceride (F), non-esterified fatty acid (G), low-density lipoprotein (H), and high-density lipoprotein (I) in the control and T2DPN groups; J: Withdrawal threshold; K: Withdrawal latency after STZ injection. Data are presented as mean ± SEM (n = 4). aP < 0.05. bP < 0.01. P indicated type 2 diabetic peripheral neuropathy group vs control group. STZ: Streptozotocin; T2DPN: Type 2 diabetic peripheral neuropathy; GTT: Glucose tolerance test; AUC: Area under the curve; Ctrl: Control; INS: Insulin; TG: Triglyceride; NEFA: Non-esterified fatty acid; LDL: Low-density lipoprotein; HDL: High-density lipoprotein.


Write to the Help Desk